Quantum-Si is building a new way to read proteins, but getting from promising prototypes to real-world lab adoption may take longer than many expect. The key question is whether delayed launches and slower repeat use of test supplies leave the company needing more funding before the business can scale.Read more
Catalysts About Quantum-Si Quantum-Si develops single molecule protein sequencing platforms and consumables for proteomics research across academic, government and commercial labs. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About Quantum-Si Quantum-Si develops single molecule protein sequencing platforms and consumables that enable advanced proteomics research across academic, biopharma and government labs. What are the underlying business or industry changes driving this perspective?Read more
No trending discussion available.
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer’s protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
